Dr Diener discusses recent stroke studies that highlight prevention efforts and where we are falling short.

Cardiology and hematology experts from Mayo Clinic review how and when DOACs should be deployed in patients with nonvalvular atrial fibrillation or at risk for VTE. They also address approved and pipeline reversal agents.

Subclinical AF, SVT nasal spray, post–AF-ablation drugs, anticoagulation and dementia risk, and the therapeutic role of diet are discussed by Dr Mandrola in this week's podcast.

A health crisis led Dr O'Donoghue to a plant-based diet. She asks why clinicians pay more respect to pills than dietary changes when poor diet affects not only heart disease but most western diseases.

Can a computer qualify someone for endovascular therapy? Should children be given tPA? Dr Mark Alberts on new stroke data.

Debating the clogged-pipe theory of CAD, subclinical AF episodes, painless cardioversion, longevity, and the nocebo effect are discussed in this week's podcast.

Drs Win-Kuang Shen and Peter Noseworthy discuss key recommendations on the diagnosis and management of syncope as published in the new ACC/AHA guidelines.

Post-MI readmissions, biomarkers in marathoners, physical activity and troponin, vasodilators in heart failure, and PCSK9i denials are the topics discussed by Dr John Mandrola in this week's podcast.

Dr Mark Alberts reviews two studies from AAN 2017 which found that door-to-needle time for tPA in acute stroke can be reduced--often drastically.

Dr P.K. Shah arrived in the US with $8, a suitcase, and a medical degree that cost about $70. The suitcase was stolen, but he went on to become an internationally recognized educator and researcher.